Artigo Acesso aberto Revisado por pares

Recommended Childhood and Adolescent Immunization Schedule—United States, 2013

2013; American Academy of Pediatrics; Volume: 131; Issue: 2 Linguagem: Inglês

10.1542/peds.2012-3706

ISSN

1098-4275

Autores

Michael T. Brady, Carrie L. Byington, H. Dele Davies, Kathryn M. Edwards, Mary P. Glodé, Mary Anne Jackson, Harry Keyserling, Yvonne Maldonado, Dennis L. Murray, Walter A. Orenstein, Gordon E. Schutze, Rodney E. Willoughby, Theoklis E. Zaoutis, Marc A. Fischer, Bruce G. Gellin, Richard L. Gorman, Lucia Lee, R. Douglas Pratt, Jennifer S. Read, Joan Robinson, Jane F. Seward, Jeffrey R. Starke, Geoffrey R. Simon, Tina Q. Tan, Carol J. Baker, Henry H. Bernstein, David W. Kimberlin, Sarah S. Long, H. Cody Meissner, L. K. Pickering, Lorry G. Rubin, Jennifer M. Frantz,

Tópico(s)

Pharmaceutical studies and practices

Resumo

The 2013 recommended childhood and adolescent immunization schedules have been approved by the American Academy of Pediatrics, the Advisory Committee on Immunization Practices of the Centers for Disease Control and Prevention, and the American Academy of Family Physicians. A change in design of the 2013 schedules has been made because of the increasing complexity of the schedules and the lack of space for new information in the footnotes. The 5-page 2013 format includes a single schedule for people 0 through 18 years of age (Fig 1), which will replace the previous schedules for people 0 to 6 years of age and 7 to 18 years of age. New columns have been added at 4 to 6 years and at 11 to 12 years of age to highlight school entry and adolescent vaccine age group recommendations. The yellow bars on the 2013 schedule contain a notation indicating the recommended dose number by age. The green catch-up bars cover the entire age range of 0 through 18 years of age (previously, the green bars were only in the schedule for 7- to 18-year-olds). The purple bars continue to designate the range of recommended ages for immunization for certain groups at high risk. The white boxes indicate ages when a vaccine is not recommended routinely. In addition, footnotes from the 0 to 6 year, 7 to 18 year, and catch-up schedules have been combined so that each footnote now contains the recommendations for routine vaccination, for catch-up vaccination, and for vaccination of children and adolescents with high-risk conditions or in special circumstances. The catch-up schedule for children and adolescents who start late or are >1 month behind remains unchanged (Fig 2). A parent-friendly vaccine schedule for children and adolescents is available at http://www.cdc.gov/vaccines/schedules/index.html. An adult immunization schedule also is published in February of each year and is available at www.cdc.gov/vaccines. These schedules are revised annually to reflect current recommendations for the use of vaccines licensed by the US Food and Drug Administration and include the following specific changes from last year:Clinically significant adverse events that follow immunization should be reported to the Vaccine Adverse Event Reporting System (VAERS). Guidance about how to obtain and complete a VAERS form can be obtained at www.vaers.hhs.gov or by calling 800-822-7967. Additional information can be found in the Red Book and at Red Book Online (http://aapredbook.aappublications.org/). Statements from the Advisory Committee on Immunization Practices of the Centers for Disease Control and Prevention that contain details of recommendations for individual vaccines, including recommendations for children with high-risk conditions, are available at www.cdc.gov/vaccines/pubs/ACIP-list.htm. Information on new vaccine releases, vaccine supplies, and interim recommendations resulting from vaccine shortages and statements on specific vaccines can be found at www.aapredbook.org/news/vaccstatus.shtml and www.cdc.gov/vaccines/pubs/ACIP-list.htm.Michael T. Brady, MD, ChairpersonCarrie L. Byington, MDH. Dele Davies, MDKathryn M. Edwards, MDMary P. Glode, MDMary Anne Jackson, MDHarry L. Keyserling, MDYvonne A. Maldonado, MDDennis L. Murray, MDWalter A. Orenstein, MDGordon E. Schutze, MDRodney E. Willoughby, MDTheoklis E. Zaoutis, MDMarc A. Fischer, MD – Centers for Disease Control and PreventionBruce Gellin, MD – National Vaccine Program OfficeRichard L. Gorman, MD – National Institutes of HealthLucia Lee, MD – Food and Drug AdministrationR. Douglas Pratt, MD – Food and Drug AdministrationJennifer S. Read, MD – National Vaccine Program OfficeJoan Robinson, MD – Canadian Pediatric SocietyMarco Aurelio Palazzi Safadi, MD – Sociedad Latinoamericana de Infectologia Pediatrica (SLIPE)Jane Seward, MBBS, MPH – Centers for Disease Control and PreventionJeffrey R. Starke, MD – American Thoracic SocietyGeoffrey Simon, MD – Committee on Practice Ambulatory MedicineTina Q. Tan, MD – Pediatric Infectious Diseases SocietyHenry H. Bernstein, DO – Red Book Online Associate EditorDavid W. Kimberlin, MD – Red Book EditorSarah S. Long, MD – Red Book Associate EditorH. Cody Meissner, MD – Visual Red Book Associate EditorJennifer Frantz, MPH

Referência(s)
Altmetric
PlumX